We are a research and innovation focused enterprise, uniquely engaged in developing novel healthcare solutions from natural sources such as plants. We follow stringent norms for standardisation, validation and product development ensuring world class quality and consistent performance; thus applying the rigours of modern science to the goodness of natural medicine. Piramal Life Sciences (PLSL) is part of the over USD 1 billion Piramal Enterprises, one of India’s largest diversified business houses. The flagship company of the Group, Piramal Healthcare Limited recently sold its domestic formulations business to Abbott and is collaborating with companies like Eli Lilly and Merck, and premier institutes in India and abroad, for discovering and developing new drugs to treat unmet medical needs. PLSL plans to leverage India’s biodiversity and vast pool of knowledge in traditional medicinal systems such as Ayurveda as a source for new medications. The company has a unique and diverse collection of natural product extracts from plants & microbes collected over a period of three decades. With 7,325 plant extracts and 53,536 microbial strains in its library the company has arguably the largest and most diverse collection of its kind in India. PLSL’s discovery process includes evaluation and investigation of plant extracts/preparations for therapeutic potential and safety, standardization and validation of promising candidates into commercial scale bio-actives, formulation development and clinical trials. The process results in standardized, evidence based phytopharmaceuticals that are at par with synthetic drugs in terms of consistent performance and quality yet preserve the holistic properties of natural medicine. PLSL thus hopes to address unmet medical needs with herbal medications by applying modern science and clinical validation techniques. PLSL plans to be a vertically integrated company with the capability to develop new products from discovery through clinical development and launch worldwide. At the same time the management is open to partnerships that can accelerate the commercialization & worldwide availability of PLSL’s proprietary products.

We are a research and innovation focused enterprise, uniquely engaged in developing novel healthcare solutions from natural sources such as plants. We follow stringent norms for standardisation, validation and product development ensuring world class quality and consistent performance; thus applying the rigours of modern science to the goodness of natural medicine. Piramal Life Sciences (PLSL) is part of the over USD 1 billion Piramal Enterprises, one of India’s largest diversified business houses. The flagship company of the Group, Piramal Healthcare Limited recently sold its domestic formulations business to Abbott and is collaborating with companies like Eli Lilly and Merck, and premier institutes in India and abroad, for discovering and developing new drugs to treat unmet medical needs. PLSL plans to leverage India’s biodiversity and vast pool of knowledge in traditional medicinal systems such as Ayurveda as a source for new medications. The company has a unique and diverse collection of natural product extracts from plants & microbes collected over a period of three decades. With 7,325 plant extracts and 53,536 microbial strains in its library the company has arguably the largest and most diverse collection of its kind in India. PLSL’s discovery process includes evaluation and investigation of plant extracts/preparations for therapeutic potential and safety, standardization and validation of promising candidates into commercial scale bio-actives, formulation development and clinical trials. The process results in standardized, evidence based phytopharmaceuticals that are at par with synthetic drugs in terms of consistent performance and quality yet preserve the holistic properties of natural medicine. PLSL thus hopes to address unmet medical needs with herbal medications by applying modern science and clinical validation techniques. PLSL plans to be a vertically integrated company with the capability to develop new products from discovery through clinical development and launch worldwide. At the same time the management is open to partnerships that can accelerate the commercialization & worldwide availability of PLSL’s proprietary products.